1. Home
  2. CYTK vs MIDD Comparison

CYTK vs MIDD Comparison

Compare CYTK & MIDD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYTK
  • MIDD
  • Stock Information
  • Founded
  • CYTK 1997
  • MIDD 1888
  • Country
  • CYTK United States
  • MIDD United States
  • Employees
  • CYTK N/A
  • MIDD N/A
  • Industry
  • CYTK Biotechnology: Pharmaceutical Preparations
  • MIDD Industrial Machinery/Components
  • Sector
  • CYTK Health Care
  • MIDD Industrials
  • Exchange
  • CYTK Nasdaq
  • MIDD Nasdaq
  • Market Cap
  • CYTK 6.7B
  • MIDD 7.4B
  • IPO Year
  • CYTK 2004
  • MIDD N/A
  • Fundamental
  • Price
  • CYTK $54.09
  • MIDD $132.70
  • Analyst Decision
  • CYTK Buy
  • MIDD Buy
  • Analyst Count
  • CYTK 15
  • MIDD 9
  • Target Price
  • CYTK $80.67
  • MIDD $159.00
  • AVG Volume (30 Days)
  • CYTK 1.2M
  • MIDD 484.6K
  • Earning Date
  • CYTK 10-31-2024
  • MIDD 08-01-2024
  • Dividend Yield
  • CYTK N/A
  • MIDD N/A
  • EPS Growth
  • CYTK N/A
  • MIDD N/A
  • EPS
  • CYTK N/A
  • MIDD 7.15
  • Revenue
  • CYTK $3,134,000.00
  • MIDD $3,907,699,000.00
  • Revenue This Year
  • CYTK $55.19
  • MIDD $0.65
  • Revenue Next Year
  • CYTK $544.53
  • MIDD $3.20
  • P/E Ratio
  • CYTK N/A
  • MIDD $18.56
  • Revenue Growth
  • CYTK N/A
  • MIDD N/A
  • 52 Week Low
  • CYTK $25.98
  • MIDD $109.59
  • 52 Week High
  • CYTK $110.25
  • MIDD $161.01
  • Technical
  • Relative Strength Index (RSI)
  • CYTK 42.69
  • MIDD 40.14
  • Support Level
  • CYTK $53.16
  • MIDD $139.01
  • Resistance Level
  • CYTK $56.87
  • MIDD $141.94
  • Average True Range (ATR)
  • CYTK 2.04
  • MIDD 2.54
  • MACD
  • CYTK -0.22
  • MIDD -1.16
  • Stochastic Oscillator
  • CYTK 16.85
  • MIDD 4.91

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle weakness, and fatigue. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

About MIDD Middleby Corporation (The)

The Middleby Corp is engaged in designing, manufacturing, marketing, distribution and service of a broad line of foodservice equipment used in all types of commercial restaurants and institutional kitchens, food preparation, cooking, baking, chilling and packaging equipment for food processing operations, and premium kitchen equipment including ranges, ovens, refrigerators, ventilation, dishwashers and outdoor cooking equipment used in the residential market. The company conducts its business through three principal business segments namely the Commercial Foodservice Equipment Group, the Food Processing Equipment Group and the Residential Kitchen Equipment Group. The firm derives majority revenue from Commercial Foodservice Equipment Group segment.

Share on Social Networks: